Citichem India Limited

Classified under 'Trading - Chemicals', Citichem India Limited operates as a BSE-listed entity dealing in chemical products, though the specific chemicals traded are not named in the filings. Revenue from operations fell nearly 50% in FY26 to Rs 9.48 crore from Rs 18.70 crore in FY25, with total revenue at Rs 15.48 crore versus Rs 54.73 crore (the latter inflated by a one-time Rs 35.20 crore write-back of sundry creditor balances). Profit after tax for FY26 stood at Rs 1.00 crore, down from Rs 1.23 crore, while EPS dropped to Rs 1.47 from Rs 2.46. Related party purchases from associate companies exceeded Rs 10 crore in FY26, suggesting that the bulk of its traded chemical volume flows through inter-group arrangements. The half-year ended September 2025 showed revenue from operations of Rs 8.52 crore against Rs 1.67 crore in H1 FY25, indicating a recovery in core trading activity within the year. Operating cash flow remained negative at Rs 5.19 crore in FY26, though improved from a Rs 11.58 crore loss the prior year, and trade receivables declined from Rs 51.08 crore to Rs 37.17 crore. Listed on the BSE SME platform in January 2025 through an IPO at Rs 70 per share, the company explored a Rs 13.63 crore preferential warrant issue during the year but later withdrew it citing adverse market conditions and lack of in-principle BSE approval.